Traders bought shares of Zoetis Inc (NYSE:ZTS) on weakness during trading on Friday following insider selling activity. $62.15 million flowed into the stock on the tick-up and $50.99 million flowed out of the stock on the tick-down, for a money net flow of $11.16 million into the stock. Of all companies tracked, Zoetis had the 32nd highest net in-flow for the day. Zoetis traded down ($0.07) for the day and closed at $91.47Specifically, insider Catherine A. Knupp sold 46,816 shares of the company’s stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $90.84, for a total value of $4,252,765.44. Following the completion of the transaction, the insider now owns 81,640 shares in the company, valued at approximately $7,416,177.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Juan Ramon Alaix sold 135,000 shares of the company’s stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $91.55, for a total value of $12,359,250.00. The disclosure for this sale can be found here. Insiders sold a total of 197,099 shares of company stock valued at $17,978,939 in the last 90 days. Corporate insiders own 0.35% of the company’s stock.

A number of brokerages have recently commented on ZTS. Argus upped their price target on Zoetis from $90.00 to $103.00 and gave the company a “buy” rating in a research report on Tuesday. Stifel Nicolaus upped their price target on Zoetis from $86.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, August 3rd. Morgan Stanley upped their price target on Zoetis from $87.00 to $92.00 and gave the company a “hold” rating in a research report on Friday, August 3rd. BMO Capital Markets reaffirmed a “hold” rating and set a $82.00 price target on shares of Zoetis in a research report on Thursday, August 2nd. Finally, Cantor Fitzgerald set a $98.00 price target on Zoetis and gave the company a “buy” rating in a research report on Thursday, August 2nd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and twelve have given a buy rating to the company. Zoetis currently has an average rating of “Buy” and a consensus target price of $90.53.

The firm has a market capitalization of $44.18 billion, a PE ratio of 37.94, a PEG ratio of 1.88 and a beta of 1.02. The company has a quick ratio of 2.92, a current ratio of 4.38 and a debt-to-equity ratio of 2.50.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Zoetis had a return on equity of 72.30% and a net margin of 19.95%. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.53 EPS. analysts anticipate that Zoetis Inc will post 3.07 earnings per share for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of ZTS. HL Financial Services LLC raised its holdings in shares of Zoetis by 8.2% in the 1st quarter. HL Financial Services LLC now owns 136,761 shares of the company’s stock valued at $11,421,000 after acquiring an additional 10,333 shares in the last quarter. FDx Advisors Inc. raised its holdings in shares of Zoetis by 35.8% in the 1st quarter. FDx Advisors Inc. now owns 92,021 shares of the company’s stock valued at $7,685,000 after acquiring an additional 24,280 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of Zoetis by 10.0% in the 1st quarter. Wells Fargo & Company MN now owns 5,845,480 shares of the company’s stock valued at $488,156,000 after acquiring an additional 531,837 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in shares of Zoetis by 26.7% in the 1st quarter. Daiwa Securities Group Inc. now owns 21,320 shares of the company’s stock valued at $1,779,000 after acquiring an additional 4,492 shares in the last quarter. Finally, Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its holdings in shares of Zoetis by 28.0% in the 1st quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 59,572 shares of the company’s stock valued at $4,805,000 after acquiring an additional 13,034 shares in the last quarter. 90.98% of the stock is currently owned by institutional investors and hedge funds.

About Zoetis (NYSE:ZTS)

Zoetis Inc discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Featured Story: Earnings Per Share (EPS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.